temozolomide has been researched along with apatinib in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 7 (100.00) | 2.80 |
Authors | Studies |
---|---|
Feng, M; Gan, W; Huang, Y; Li, X; Liu, J; Shao, Y; Wang, X; Yao, H; Zhang, C; Zhou, Y | 1 |
Sun, X; Xu, X; Xu, Y; Zhan, W; Zhao, L; Zhu, Y | 1 |
Bai, X; Chi, Z; Cui, C; Guo, J; Li, S; Lian, B; Mao, L; Sheng, X; Si, L; Tang, B; Wang, X; Yan, X; Yang, Y; Zhou, L | 1 |
Li, J; Shen, Z; Shi, L; Zhang, N; Zhao, S | 1 |
Kan, ANC; Ku, DTL; Lam, YL; Liu, APY; To, KF; Yan, CLS; Yu, SH | 1 |
Cheng, P; Han, Q; Ma, H; Yang, H; Zhao, M; Zhao, Y | 1 |
Bai, X; Cheng, F; Chi, Z; Cui, C; Dai, J; Duan, R; Guo, J; Kong, Y; Li, C; Li, J; Li, S; Lian, B; Mao, L; Pang, Z; Sheng, X; Si, L; Tang, B; Wang, X; Wei, X; Wu, X; Xia, F; Xu, H; Yan, X; Yang, Y; Zhang, C; Zhou, L | 1 |
1 review(s) available for temozolomide and apatinib
Article | Year |
---|---|
Combining apatinib and temozolomide for brainstem glioblastoma: a case report and review of literature.
Topics: Adult; Brain Neoplasms; Brain Stem; Dacarbazine; Glioblastoma; Humans; Male; Pyridines; Temozolomide | 2022 |
2 trial(s) available for temozolomide and apatinib
Article | Year |
---|---|
Phase II study of apatinib combined with temozolomide in patients with advanced melanoma after failure of immunotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Humans; Immunotherapy; Melanoma; Pyridines; Skin Neoplasms; Temozolomide | 2022 |
Camrelizumab Plus Apatinib and Temozolomide as First-Line Treatment in Patients With Advanced Acral Melanoma: The CAP 03 Phase 2 Nonrandomized Clinical Trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Humans; Male; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Temozolomide; Vascular Endothelial Growth Factor A | 2023 |
4 other study(ies) available for temozolomide and apatinib
Article | Year |
---|---|
Clinical study of apatinib plus temozolomide for the treatment of recurrent high-grade gliomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Brain Neoplasms; Drug Therapy, Combination; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Pyridines; Quality of Life; Survival Rate; Temozolomide; Treatment Outcome | 2021 |
Apatinib and temozolomide in children with recurrent ependymoma: A case report.
Topics: Antineoplastic Agents; Brain Neoplasms; Child; Child, Preschool; Cisplatin; Ependymoma; Humans; Male; Protein Kinase Inhibitors; Pyridines; Temozolomide | 2022 |
Durable disease control with apatinib, irinotecan and temozolomide in a case of metastatic primitive myxoid mesenchymal tumour of infancy.
Topics: Humans; Infant; Irinotecan; Neoplasms; Pyridines; Temozolomide | 2023 |
Apatinib combined with temozolomide treatment for pseudoprogression in glioblastoma: A case report.
Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Temozolomide | 2022 |